Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2025-04-30 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-04-30 English
News release - English.pdf
Regulatory Filings
2025-04-29 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a notice from the company’s transfer agent (TSX Trust) confirming that proxy-related materials (proxy, voting instruction form, notice of meeting, information circular) have been mailed to shareholders. This falls squarely under proxy solicitation materials sent to shareholders to provide information and request votes, matching the definition of Proxy Solicitation & Information Statement (PSI).
2025-04-23 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a formal notice of an Annual and Special Meeting of Shareholders, including details on meeting date, time, agenda items, voting procedures, proxies and references to the management information circular. These are materials sent to shareholders to request votes and provide meeting information, matching the Proxy Solicitation & Information Statement category.
2025-04-22 English
Other.pdf
Regulatory Filings Classification · 89% confidence The document is a compliance certificate under Canada’s National Instrument 54-101 certifying arrangements for distribution of proxy materials to beneficial owners before the shareholder meeting. It is not the actual proxy statement or meeting materials, nor is it reporting results; it is a regulatory compliance filing. As such it does not fit any specialized category (AGM materials, proxy statement, voting results, etc.) and best maps to the general "Regulatory Filings" fallback.
2025-04-22 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a form of proxy (“Proxy”) for the Annual and Special Meeting, soliciting votes, detailing voting instructions, resolutions, record date, and proxy appointment guidelines. This aligns with Proxy Solicitation & Information Statement materials (PSI) rather than the meeting presentation itself. Therefore, classification is PSI.
2025-04-22 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.